<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39073768</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1755-3245</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>14</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>25</Day></PubDate></JournalIssue><Title>Cardiovascular research</Title><ISOAbbreviation>Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.</ArticleTitle><Pagination><StartPage>1752</StartPage><EndPage>1767</EndPage><MedlinePgn>1752-1767</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cvr/cvae159</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">While acute cardiovascular complications of coronavirus disease 2019 (COVID-19) are well described, less is known about longer-term cardiac sequelae. For many individuals with cardiac signs or symptoms arising after COVID-19 infection, the aetiology remains unclear. We examined immune profiles associated with magnetic resonance imaging (MRI) abnormalities in patients with unexplained cardiac injury after COVID-19.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Twenty-one participants {mean age 47 [standard deviation (SD) 13] years, 71% female} with long COVID-19 (n = 17), raised troponin (n = 2), or unexplained new-onset heart failure (n = 2), who did not have pre-existing heart conditions or recent steroid/immunosuppression treatment, were enrolled a mean 346 (SD 191) days after COVID-19 infection in a prospective observational study. Cardiac MRI and blood sampling for deep immunophenotyping using mass cytometry by time of flight and measurement of proteomic inflammatory markers were performed. Nine of the 21 (43%) participants had MRI abnormalities (MRI(+)), including non-ischaemic patterns of late gadolinium enhancement and/or visually overt myocardial oedema in 8 people. One patient had mildly impaired biventricular function without fibrosis or oedema, and two had severe left ventricular (LV) impairment. MRI(+) individuals had higher blood CCL3, CCL7, FGF-23, and CD4 Th2 cells, and lower CD8 T effector memory (TEM) cells, than MRI(-). Cluster analysis revealed lower expression of inhibitory receptors PD1 and TIM3 in CD8 TEM cells from MRI(+) patients than MRI(-) patients, and functional studies of CD8 T &#x3b1;&#x3b2; cells showed higher proportions of cytotoxic granzyme B+(GZB+)-secreting cells upon stimulation. CD8 TEM cells and CCL7 were the strongest predictors of MRI abnormalities in a least absolute shrinkage and selection operator regression model (composite area under the curve 0.96, 95% confidence interval 0.88-1.0). CCL7 was correlated with diffuse myocardial fibrosis/oedema detected by quantitative T1 mapping (r = 0.47, P = 0.04).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">COVID-19-related cardiac injury in symptomatic patients with non-ischaemic myocarditis-like MRI abnormalities is associated with immune dysregulation, including decreased peripheral CD8 TEM cells and increased CCL7, persisting long after the initial infection.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#x106;orovi&#x107;</LastName><ForeName>Andrej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiaohui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newland</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopalan</LastName><ForeName>Deepa</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8079-205X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Cambridge University Hospitals NHS Trust, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giakomidi</LastName><ForeName>Despina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yarkoni</LastName><ForeName>Natalia S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Cell Phenotyping Hub, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peverelli</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sriranjan</LastName><ForeName>Rouchelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graves</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sage</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sithole</LastName><ForeName>Nyarie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudd</LastName><ForeName>James H F</ForeName><Initials>JHF</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallat</LastName><ForeName>Ziad</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Tian X</ForeName><Initials>TX</Initials><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nus</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6378-8910</Identifier><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarkin</LastName><ForeName>Jason M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-9132-120X</Identifier><AffiliationInfo><Affiliation>Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Cambridge British Heart Foundation</Agency><Country/></Grant><Grant><GrantID>18/1/34212</GrantID><Agency>(BHF) Centre of Research Excellence</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Res</MedlineTA><NlmUniqueID>0077427</NlmUniqueID><ISSNLinking>0008-6363</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004489" MajorTopicYN="N">Edema, Cardiac</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Immunophenotyping</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword></KeywordList><CoiStatement>Conflict of interest: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39073768</ArticleId><ArticleId IdType="pmc">PMC11587552</ArticleId><ArticleId IdType="doi">10.1093/cvr/cvae159</ArticleId><ArticleId IdType="pii">7723296</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Giacca &#xa0;M, Shah &#xa0;AM. The pathological maelstrom of COVID-19 and cardiovascular disease. Nat Cardiovasc Res &#xa0;2022;1:200&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">39195986</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi &#xa0;S, Qin &#xa0;M, Shen &#xa0;B, Cai &#xa0;Y, Liu &#xa0;T, Yang &#xa0;F, Gong &#xa0;W, Liu &#xa0;X, Liang &#xa0;J, Zhao &#xa0;Q, Huang &#xa0;H, Yabg &#xa0;B, Huang &#xa0;C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol &#xa0;2020;5:802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen &#xa0;T, Wu &#xa0;D, Chen &#xa0;H, Yan &#xa0;W, Yang &#xa0;D, Chen &#xa0;G, Ma &#xa0;K, Xu &#xa0;D, Yu &#xa0;H, Wang &#xa0;H, Wang &#xa0;T, Guo &#xa0;W, Chen &#xa0;J, Ding &#xa0;C, Zhang &#xa0;X, Huang &#xa0;J, Han &#xa0;M, Li &#xa0;S, Luo &#xa0;X, Zhao &#xa0;J, Ning &#xa0;Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ &#xa0;2020;368:m1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo &#xa0;T, Fan &#xa0;Y, Chen &#xa0;M, Wu &#xa0;X, Zhang &#xa0;L, He &#xa0;T, Wang &#xa0;H, Wan &#xa0;J, Wang &#xa0;X, Lu &#xa0;Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol &#xa0;2020;5:811&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou &#xa0;F, Yu &#xa0;T, Du &#xa0;R, Fan &#xa0;G, Liu &#xa0;Y, Liu &#xa0;Z, Xiang &#xa0;J, Wang &#xa0;Y, Song &#xa0;B, Gu &#xa0;X, Guan &#xa0;L, Wei &#xa0;Y, Li &#xa0;H, Wu &#xa0;X, Xu &#xa0;J, Tu &#xa0;S, Zhang &#xa0;Y, Chen &#xa0;H, Cao &#xa0;B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet &#xa0;2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman &#xa0;B, Bluemke &#xa0;DA, L&#xfc;scher &#xa0;TF, Neubauer &#xa0;S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J &#xa0;2022;43:1157&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie &#xa0;Y, Xu &#xa0;E, Bowe &#xa0;B, Al-Aly &#xa0;Z. Long-term cardiovascular outcomes of COVID-19. Nat Med &#xa0;2022;28:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati &#xa0;E, Lupi &#xa0;L, Palazzini &#xa0;M, Hendren &#xa0;NS, Grodin &#xa0;JL, Cannistraci &#xa0;CV, Schmidt &#xa0;M, Hekimian &#xa0;G, Peretto &#xa0;G, Bochaton &#xa0;T, Hayek &#xa0;A, Piriou &#xa0;N, Leonardi &#xa0;S, Guida &#xa0;S, Turco &#xa0;A, Sala &#xa0;S, Uribarri &#xa0;A, de Heyning &#xa0;CMV, Mapelli &#xa0;M, Campodonico &#xa0;J, Pedrotti &#xa0;P, S&#xe1;nchez &#xa0;MIB, Sole &#xa0;AA, Marini &#xa0;M, Matassini &#xa0;MV, Vourc&#x2019;h &#xa0;M, Cannat&#xe0; &#xa0;A, Bromage &#xa0;DI, Briguglia &#xa0;D, Salamanca &#xa0;J, Diez-Villanueva &#xa0;P, Lehtonen &#xa0;J, Huang &#xa0;F, Russel &#xa0;S, Soriano &#xa0;F, Turrini &#xa0;F, Cipriani &#xa0;M, Bramerio &#xa0;M, Pasquale &#xa0;MD, Grosu &#xa0;A, Senni &#xa0;M, Farina &#xa0;D, Agostoni &#xa0;P, Rizzo &#xa0;S, Gaspari &#xa0;MD, Marzo &#xa0;F, Duran &#xa0;JM, Adler &#xa0;ED, Giannattasio &#xa0;C, Basso &#xa0;C, McDonagh &#xa0;T, Kerneis &#xa0;M, Combes &#xa0;A, Camici &#xa0;PG, de Lemos &#xa0;JA, Metra &#xa0;M. Prevalence, characteristics, and outcomes of COVID-19&#x2013;associated acute myocarditis. Circulation &#xa0;2022;145:1123&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989611</ArticleId><ArticleId IdType="pubmed">35404682</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby &#xa0;P. The heart in COVID-19 primary target or secondary bystander? &#xa0;JACC Basic Transl Sci &#xa0;2020;5:537&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151324</ArticleId><ArticleId IdType="pubmed">32292847</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmerov &#xa0;A, Marb&#xe1;n &#xa0;E. COVID-19 and the heart. Circ Res &#xa0;2020;579:482&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">32252591</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini &#xa0;GG, Montorfano &#xa0;M, Trabattoni &#xa0;D, Andreini &#xa0;D, Ferrante &#xa0;G, Ancona &#xa0;M, Metra &#xa0;M, Curello &#xa0;S, Maffeo &#xa0;D, Pero &#xa0;G, Cacucci &#xa0;M, Assanelli &#xa0;E, Bellini &#xa0;B, Russo &#xa0;F, Ielasi &#xa0;A, Tespili &#xa0;M, Danzi &#xa0;GB, Vandoni &#xa0;P, Bollati &#xa0;M, Barbieri &#xa0;L, Oreglia &#xa0;J, Lettieri &#xa0;C, Cremonesi &#xa0;A, Carugo &#xa0;S, Reimers &#xa0;B, Condorelli &#xa0;G, Chieffo &#xa0;A. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation &#xa0;2020;141:2113&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302062</ArticleId><ArticleId IdType="pubmed">32352306</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini &#xa0;D, Kawakami &#xa0;R, Guagliumi &#xa0;G, Sakamoto &#xa0;A, Kawai &#xa0;K, Gianatti &#xa0;A, Nasr &#xa0;A, Kutys &#xa0;R, Guo &#xa0;L, Cornelissen &#xa0;A, Faggi &#xa0;L, Mori &#xa0;M, Sato &#xa0;Y, Pescetelli &#xa0;I, Brivio &#xa0;M, Romero &#xa0;M, Virmani &#xa0;R, Finn &#xa0;AV. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation &#xa0;2021;143:1031&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">33480806</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka &#xa0;MK, Vander Heide &#xa0;RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol &#xa0;2021;50:107300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck &#xa0;MR, Bularga &#xa0;A, Hahn &#xa0;RT, Bing &#xa0;R, Lee &#xa0;KK, Chapman &#xa0;AR, White &#xa0;A, Salvo &#xa0;GD, Sade &#xa0;LE, Pearce &#xa0;K, Newby &#xa0;DE, Popescu &#xa0;BA, Donal &#xa0;E, Cosyns &#xa0;B, Edvardsen &#xa0;T, Mills &#xa0;NL, Haugaa &#xa0;K. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging &#xa0;2020;21:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman &#xa0;B, Cassar &#xa0;MP, Tunnicliffe &#xa0;EM, Filippini &#xa0;N, Griffanti &#xa0;L, Alfaro-Almagro &#xa0;F, Okell &#xa0;T, Sheerin &#xa0;F, Xie &#xa0;C, Mahmod &#xa0;M, M&#xf3;zes &#xa0;FE, Lewandowski &#xa0;AJ, Ohuma &#xa0;EO, Holdsworth &#xa0;D, Lamlum &#xa0;H, Woodman &#xa0;MJ, Krasopoulos &#xa0;C, Mills &#xa0;R, McConnell &#xa0;FAK, Wang &#xa0;C, Arthofer &#xa0;C, Lange &#xa0;FJ, Andersson &#xa0;J, Jenkinson &#xa0;M, Antoniades &#xa0;C, Channon &#xa0;KM, Shanmuganathan &#xa0;M, Ferreira &#xa0;VM, Piechnik &#xa0;SK, Klenerman &#xa0;P, Brightling &#xa0;C, Talbot &#xa0;NP, Petousi &#xa0;N, Rahman &#xa0;NM, Ho &#xa0;L-P, Saunders &#xa0;K, Geddes &#xa0;JR, Harrison &#xa0;PJ, Pattinson &#xa0;K, Rowland &#xa0;MJ, Angus &#xa0;BJ, Gleeson &#xa0;F, Pavlides &#xa0;M, Koychev &#xa0;I, Miller &#xa0;KL, Mackay &#xa0;C, Jezzard &#xa0;P, Smith &#xa0;SM, Neubauer &#xa0;S. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine &#xa0;2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Artico &#xa0;J, Shiwani &#xa0;H, Moon &#xa0;JC, Gorecka &#xa0;M, McCann &#xa0;GP, Roditi &#xa0;G, Morrow &#xa0;A, Mangion &#xa0;K, Lukaschuk &#xa0;E, Shanmuganathan &#xa0;M, Miller &#xa0;CA, Chiribiri &#xa0;A, Prasad &#xa0;SK, Adam &#xa0;RD, Singh &#xa0;T, Bucciarelli-Ducci &#xa0;C, Dawson &#xa0;D, Knight &#xa0;D, Fontana &#xa0;M, Manisty &#xa0;C, Treibel &#xa0;TA, Levelt &#xa0;E, Arnold &#xa0;R, Macfarlane &#xa0;PW, Young &#xa0;R, McConnachie &#xa0;A, Neubauer &#xa0;S, Piechnik &#xa0;SK, Davies &#xa0;RH, Ferreira &#xa0;VM, Dweck &#xa0;MR, Berry &#xa0;C; OxAMI (Oxford Acute Myocardial Infarction Study) Investigators; COVID-HEART Investigators&#x2020;; Greenwood &#xa0;JP. Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation &#xa0;2023;147:364&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9889203</ArticleId><ArticleId IdType="pubmed">36705028</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Carerj &#xa0;ML, Wieters &#xa0;I, Fahim &#xa0;M, Arendt &#xa0;C, Hoffmann &#xa0;J, Shchendrygina &#xa0;A, Escher &#xa0;F, Vasa-Nicotera &#xa0;M, Zeiher &#xa0;AM, Vehreschild &#xa0;M, Nagel &#xa0;E. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol &#xa0;2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha &#xa0;T, Knight &#xa0;DS, Razvi &#xa0;Y, Kumar &#xa0;K, Vimalesvaran &#xa0;K, Thornton &#xa0;G, Patel &#xa0;R, Chacko &#xa0;L, Brown &#xa0;JT, Coyle &#xa0;C, Leith &#xa0;D, Shetye &#xa0;A, Ariff &#xa0;B, Bell &#xa0;R, Captur &#xa0;G, Coleman &#xa0;M, Goldring &#xa0;J, Gopalan &#xa0;D, Heightman &#xa0;M, Hillman &#xa0;T, Howard &#xa0;L, Jacobs &#xa0;M, Jeetley &#xa0;PS, Kanagaratnam &#xa0;P, Kon &#xa0;OM, Lamb &#xa0;LE, Manisty &#xa0;CH, Mathurdas &#xa0;P, Mayet &#xa0;J, Negus &#xa0;R, Patel &#xa0;N, Pierce &#xa0;I, Russell &#xa0;G, Wolff &#xa0;A, Xue &#xa0;H, Kellman &#xa0;P, Moon &#xa0;JC, Treibel &#xa0;TA, Cole &#xa0;GD, Fontana &#xa0;M. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J &#xa0;2021;42:1866&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Martin &#xa0;S, Shchendrygina &#xa0;A, Hoffmann &#xa0;J, Ka &#xa0;MM, Giokoglu &#xa0;E, Vanchin &#xa0;B, Holm &#xa0;N, Karyou &#xa0;A, Laux &#xa0;GS, Arendt &#xa0;C, De Leuw &#xa0;P, Zacharowski &#xa0;K, Khodamoradi &#xa0;Y, Vehreschild &#xa0;MJGT, Rohde &#xa0;G, Zeiher &#xa0;AM, Vogl &#xa0;TJ, Schwenke &#xa0;C, Nagel &#xa0;E. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med &#xa0;2022;28:2117&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal &#xa0;SM, Landers &#xa0;DB, Hollenberg &#xa0;SM, Turi &#xa0;ZG, Glotzer &#xa0;TV, Tancredi &#xa0;J, Parrillo &#xa0;JE. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol &#xa0;2022;79:2325&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi &#xa0;L, Mescia &#xa0;F, Turner &#xa0;L, Hanson &#xa0;AL, Kotagiri &#xa0;P, Dunmore &#xa0;BJ, Ruffieux &#xa0;H, De Sa &#xa0;A, Huhn &#xa0;O, Morgan &#xa0;MD, Gerber &#xa0;PP, Wills &#xa0;MR, Baker &#xa0;S, Calero-Nieto &#xa0;FJ, Doffinger &#xa0;R, Dougan &#xa0;G, Elmer &#xa0;A, Goodfellow &#xa0;IG, Gupta &#xa0;RK, Hosmillo &#xa0;M, Hunter &#xa0;K, Kingston &#xa0;N, Lehner &#xa0;PJ, Matheson &#xa0;NJ, Nicholson &#xa0;JK, Petrunkina &#xa0;AM, Richardson &#xa0;S, Saunders &#xa0;C, Thaventhiran &#xa0;JED, Toonen &#xa0;EJM, Weekes &#xa0;MP; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration; G&#xf6;ttgens &#xa0;B, Toshner &#xa0;M, Hess &#xa0;C, Bradley &#xa0;JR, Lyons &#xa0;PA, Smith &#xa0;KGC. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity &#xa0;2021;54:1257&#x2013;1275.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu &#xa0;Z, van der Ploeg &#xa0;K, Chakraborty &#xa0;S, Arunachalam &#xa0;PS, Mori &#xa0;DA, Jacobson &#xa0;KB, Bonilla &#xa0;H, Parsonnet &#xa0;J, Andrews &#xa0;JR, Holubar &#xa0;M, Subramanian &#xa0;A, Khosla &#xa0;C, Maldonado &#xa0;Y, Hedlin &#xa0;H, de la Parte &#xa0;L, Press &#xa0;K, Ty &#xa0;M, Tan &#xa0;GS, Blish &#xa0;C, Takahashi &#xa0;S, Rodriguez-Barraquer &#xa0;I, Greenhouse &#xa0;B, Butte &#xa0;AJ, Singh &#xa0;U, Pulendran &#xa0;B, Wang &#xa0;TT, Jagannathan &#xa0;P. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife &#xa0;2022;11:e77943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566856</ArticleId><ArticleId IdType="pubmed">36239699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer &#xa0;W, Weber &#xa0;M, Diehl-Wiesenecker &#xa0;E, Galtung &#xa0;N, Prpic &#xa0;M, Somasundaram &#xa0;R, Tauber &#xa0;R, Schwenk &#xa0;JM, Micke &#xa0;P, Kappert &#xa0;K. Plasma proteome fingerprints reveal distinctiveness and clinical outcome of SARS-CoV-2 infection. Viruses &#xa0;2021;13:2456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8706135</ArticleId><ArticleId IdType="pubmed">34960725</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Deitchman &#xa0;AN, Torres &#xa0;L, Iyer &#xa0;NS, Munter &#xa0;SE, Nixon &#xa0;CC, Donatelli &#xa0;J, Thanh &#xa0;C, Takahashi &#xa0;S, Hakim &#xa0;J, Turcios &#xa0;K, Janson &#xa0;O, Hoh &#xa0;R, Tai &#xa0;V, Hernandez &#xa0;Y, Fehrman &#xa0;EA, Spinelli &#xa0;MA, Gandhi &#xa0;M, Trinh &#xa0;L, Wrin &#xa0;T, Petropoulos &#xa0;CJ, Aweeka &#xa0;FT, Rodriguez-Barraquer &#xa0;I, Kelly &#xa0;JD, Martin &#xa0;JN, Deeks &#xa0;SG, Greenhouse &#xa0;B, Rutishauser &#xa0;RL, Henrich &#xa0;TJ. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep &#xa0;2021;36:109518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh &#xa0;C, Darley &#xa0;DR, Wilson &#xa0;DB, Howe &#xa0;A, Munier &#xa0;CML, Patel &#xa0;SK, Juno &#xa0;JA, Burrell &#xa0;LM, Kent &#xa0;SJ, Dore &#xa0;GJ, Kelleher &#xa0;AD, Matthews &#xa0;GV. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol &#xa0;2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein &#xa0;J, Wood &#xa0;J, Jaycox &#xa0;J, Lu &#xa0;P, Dhodapkar &#xa0;RM, Gehlhausen &#xa0;JR, Tabachnikova &#xa0;A, Tabacof &#xa0;L, Malik &#xa0;AA, Kamath &#xa0;K, Greene &#xa0;K, Monteiro &#xa0;VS, Pe&#xf1;a-Hernandez &#xa0;M, Mao &#xa0;T, Bhattacharjee &#xa0;B, Takahashi &#xa0;T, Lucas &#xa0;C, Silva &#xa0;J, Mccarthy &#xa0;D, Breyman &#xa0;E, Tosto-Mancuso &#xa0;J, Dai &#xa0;Y, Perotti &#xa0;E, Akduman &#xa0;K, Tzeng &#xa0;TJ, Xu &#xa0;L, Yildirim &#xa0;I, Krumholz &#xa0;HM, Shon &#xa0;J, Medzhitov &#xa0;R, Omer &#xa0;SB, van Dijk &#xa0;D, Ring &#xa0;AM, Putrino &#xa0;D, Iwasaki &#xa0;A. Distinguishing features of Long COVID identified through immune profiling. MedRxiv 22278592. 10.1101/2022.08.09.22278592, 10 August 2022, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah &#xa0;W, Hillman &#xa0;T, Playford &#xa0;ED, Hishmeh &#xa0;L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ &#xa0;2021;372:n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawel-Boehm &#xa0;N, Hetzel &#xa0;SJ, Ambale-Venkatesh &#xa0;B, Captur &#xa0;G, Francois &#xa0;CJ, Jerosch-Herold &#xa0;M, Salerno &#xa0;M, Teague &#xa0;SD, Valsangiacomo-Buechel &#xa0;E, van der Geest &#xa0;RJ, Bluemke &#xa0;DA. Reference ranges (&#x201c;normal values&#x201d;) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiov Magn Reson &#xa0;2020;22:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734766</ArticleId><ArticleId IdType="pubmed">33308262</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte &#xa0;CE, Tumes &#xa0;DJ, Liston &#xa0;A, Burton &#xa0;OT. Do more with less: improving high parameter cytometry through overnight staining. Curr Protoc &#xa0;2022;2:e589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9827877</ArticleId><ArticleId IdType="pubmed">36373983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu &#xa0;Z, Eils &#xa0;R, Schlesner &#xa0;M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics &#xa0;2016;32:2847&#x2013;2849.</Citation><ArticleIdList><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahne &#xa0;F, Le Meur &#xa0;N, Brinkman &#xa0;RR, Ellis &#xa0;B, Haaland &#xa0;P, Sarkar &#xa0;D, Spidlen &#xa0;J, Strain &#xa0;E, Gentleman &#xa0;R. flowCore: a Bioconductor package for high throughput flow cytometry. BMC Bioinformatics &#xa0;2009;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2684747</ArticleId><ArticleId IdType="pubmed">19358741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao &#xa0;Y, Stuart &#xa0;T, Kowalski &#xa0;MH, Choudhary &#xa0;S, Hoffman &#xa0;P, Hartman &#xa0;A, Srivastava &#xa0;A, Molla &#xa0;G, Madad &#xa0;S, Fernandez-Granda &#xa0;C, Satija &#xa0;R. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol &#xa0;2024;42:293&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10928517</ArticleId><ArticleId IdType="pubmed">37231261</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk &#xa0;D, Kirsch &#xa0;R, Koutrouli &#xa0;M, Nastou &#xa0;K, Mehryary &#xa0;F, Hachilif &#xa0;R, Gable &#xa0;AL, Fang &#xa0;T, Doncheva &#xa0;NT, Pyysalo &#xa0;S, Bork &#xa0;P, Jensen &#xa0;LJ, von Mering &#xa0;C. The STRING database in 2023: protein&#x2013;protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res &#xa0;2022;51:D638&#x2013;D646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna &#xa0;BA, Lim &#xa0;EY, Mactavous &#xa0;L, Team &#xa0;NB, Lyons &#xa0;PA, Doffinger &#xa0;R, Bradley &#xa0;JR, Smith &#xa0;KGC, Sinclair &#xa0;J, Matheson &#xa0;NJ, Lehner &#xa0;PJ, Wills &#xa0;MR, Sithole &#xa0;N. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine &#xa0;2022;81:104129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira &#xa0;VM, Schulz-Menger &#xa0;J, Holmvang &#xa0;G, Kramer &#xa0;CM, Carbone &#xa0;I, Sechtem &#xa0;U, Kindermann &#xa0;I, Gutberlet &#xa0;M, Cooper &#xa0;LT, Liu &#xa0;P, Friedrich &#xa0;MG. Cardiovascular magnetic resonance in nonischemic myocardial inflammation expert recommendations. J Am Coll Cardiol &#xa0;2018;72:3158&#x2013;3176.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tippalagama &#xa0;R, Singhania &#xa0;A, Dubelko &#xa0;P, Lindestam Arlehamn &#xa0;CS, Crinklaw &#xa0;A, Pomaznoy &#xa0;M, Seumois &#xa0;G, deSilva &#xa0;AD, Premawansa &#xa0;S, Vidanagama &#xa0;D, Gunasena &#xa0;B, Goonawardhana &#xa0;NDS, Ariyaratne &#xa0;D, Scriba &#xa0;TJ, Gilman &#xa0;RH, Saito &#xa0;M, Taplitz &#xa0;R, Vijayanand &#xa0;P, Sette &#xa0;A, Peters &#xa0;B, Burel &#xa0;JG. HLA-DR marks recently divided antigen-specific effector CD4T cells in active tuberculosis patients. J Immunol &#xa0;2021;207:523&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516689</ArticleId><ArticleId IdType="pubmed">34193602</ArticleId></ArticleIdList></Reference><Reference><Citation>Weninger &#xa0;W, Crowley &#xa0;MA, Manjunath &#xa0;N, von Andrian &#xa0;UH. Migratory properties of naive, effector, and memory Cd8+ T cells. J Exp Med &#xa0;2001;194:953&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193483</ArticleId><ArticleId IdType="pubmed">11581317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou &#xa0;C-L, Peters &#xa0;W, Si &#xa0;Y, Slaymaker &#xa0;S, Aslanian &#xa0;AM, Weisberg &#xa0;SP, Mack &#xa0;M, Charo &#xa0;IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest &#xa0;2007;117:902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1810572</ArticleId><ArticleId IdType="pubmed">17364026</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann &#xa0;D, Savvatis &#xa0;K, Lindner &#xa0;D, Zietsch &#xa0;C, Becher &#xa0;PM, Hammer &#xa0;E, Heimesaat &#xa0;MM, Bereswill &#xa0;S, V&#xf6;lker &#xa0;U, Escher &#xa0;F, Riad &#xa0;A, Plendl &#xa0;J, Klingel &#xa0;K, Poller &#xa0;W, Schultheiss &#xa0;H-P, Tsch&#xf6;pe &#xa0;C. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation &#xa0;2011;124:2082&#x2013;2093.</Citation><ArticleIdList><ArticleId IdType="pubmed">21986287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardina &#xa0;SV, Michlmayr &#xa0;D, Hoffman &#xa0;KW, Obara &#xa0;CJ, Sum &#xa0;J, Charo &#xa0;IF, Lu &#xa0;W, Pletnev &#xa0;AG, Lim &#xa0;JK. Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during West Nile virus infection. J Immunol &#xa0;2015;195:4306&#x2013;4318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4610864</ArticleId><ArticleId IdType="pubmed">26401006</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso &#xa0;C, Leone &#xa0;O, Rizzo &#xa0;S, De Gaspari &#xa0;M, van der Wal &#xa0;AC, Aubry &#xa0;M-C, Bois &#xa0;MC, Lin &#xa0;PT, Maleszewski &#xa0;JJ, Stone &#xa0;JR. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J &#xa0;2020;41:3827&#x2013;3835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao &#xa0;M, Liu &#xa0;Y, Yuan &#xa0;J, Wen &#xa0;Y, Xu &#xa0;G, Zhao &#xa0;J, Cheng &#xa0;L, Li &#xa0;J, Wang &#xa0;X, Wang &#xa0;F, Liu &#xa0;L, Amit &#xa0;I, Zhang &#xa0;S, Zhang &#xa0;Z. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med &#xa0;2020;26:842&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen &#xa0;L, Wang &#xa0;G, Tan &#xa0;J, Cao &#xa0;Y, Long &#xa0;X, Luo &#xa0;H, Tang &#xa0;Q, Jiang &#xa0;T, Wang &#xa0;W, Zhou &#xa0;J. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality. Signal Transduct Target Ther &#xa0;2020;5:292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734384</ArticleId><ArticleId IdType="pubmed">33318472</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang &#xa0;T-T, Chen &#xa0;C, Chen &#xa0;J-W. CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease. Cardiovasc Diabetol &#xa0;2022;21:185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9479413</ArticleId><ArticleId IdType="pubmed">36109744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouggari &#xa0;Y, Ait-Oufella &#xa0;H, Bonnin &#xa0;P, Simon &#xa0;T, Sage &#xa0;AP, Gu&#xe9;rin &#xa0;C, Vilar &#xa0;J, Caligiuri &#xa0;G, Tsiantoulas &#xa0;D, Laurans &#xa0;L, Dumeau &#xa0;E, Kotti &#xa0;S, Bruneval &#xa0;P, Charo &#xa0;IF, Binder &#xa0;CJ, Danchin &#xa0;N, Tedgui &#xa0;A, Tedder &#xa0;TF, Silvestre &#xa0;J-S, Mallat &#xa0;Z. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med &#xa0;2013;19:1273&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4042928</ArticleId><ArticleId IdType="pubmed">24037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares &#xa0;MBP, de Lima &#xa0;RS, Rocha &#xa0;LL, Vasconcelos &#xa0;JF, Rogatto &#xa0;SR, dos Santos &#xa0;RR, Iacobas &#xa0;S, Goldenberg &#xa0;RC, Iacobas &#xa0;DA, Tanowitz &#xa0;HB, de Carvalho &#xa0;ACC, Spray &#xa0;DC. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. J Infect Dis &#xa0;2010;202:416&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897928</ArticleId><ArticleId IdType="pubmed">20565256</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellino &#xa0;F, Huang &#xa0;AY, Altan-Bonnet &#xa0;G, Stoll &#xa0;S, Scheinecker &#xa0;C, Germain &#xa0;RN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell&#x2013;dendritic cell interaction. Nature &#xa0;2006;440:890&#x2013;895.</Citation><ArticleIdList><ArticleId IdType="pubmed">16612374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuse &#xa0;K, Kodomama &#xa0;M, Ito &#xa0;M, Okura &#xa0;Y, Kato &#xa0;K, Hanawa &#xa0;H, Aoki &#xa0;S, Aizawa &#xa0;Y. Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol &#xa0;2003;134:403&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1808899</ArticleId><ArticleId IdType="pubmed">14632744</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz &#xa0;T, Harmel &#xa0;E, Heier &#xa0;M, Peters &#xa0;A, Linseisen &#xa0;J, Meisinger &#xa0;C. Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction. J Transl Med &#xa0;2022;20:457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9547640</ArticleId><ArticleId IdType="pubmed">36209229</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares-Schanoski &#xa0;A, Sauerwald &#xa0;N, Goforth &#xa0;CW, Periasamy &#xa0;S, Weir &#xa0;DL, Lizewski &#xa0;S, Lizewski &#xa0;R, Ge &#xa0;Y, Kuzmina &#xa0;NA, Nair &#xa0;VD, Vangeti &#xa0;S, Marjanovic &#xa0;N, Cappuccio &#xa0;A, Cheng &#xa0;WS, Mofsowitz &#xa0;S, Miller &#xa0;CM, Yu &#xa0;XB, George &#xa0;M-C, Zaslavsky &#xa0;E, Bukreyev &#xa0;A, Troyanskaya &#xa0;OG, Sealfon &#xa0;SC, Letizia &#xa0;AG, Ramos &#xa0;I. Asymptomatic SARS-CoV-2 infection is associated with higher levels of serum IL-17C, matrix metalloproteinase 10 and fibroblast growth factors than mild symptomatic COVID-19. Front Immunol &#xa0;2022;13:821730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9037090</ArticleId><ArticleId IdType="pubmed">35479098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha &#xa0;M-S, Shin &#xa0;E-C. Activation or exhaustion of CD8+ T cells in patients with COVID-19. Cell Mol Immunol &#xa0;2021;18:2325&#x2013;2333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374113</ArticleId><ArticleId IdType="pubmed">34413488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech &#xa0;M, Chroscicki &#xa0;P, Swatler &#xa0;J, Stepnik &#xa0;D, De Biasi &#xa0;S, Hampel &#xa0;M, Brewinska-Olchowik &#xa0;M, Maliszewska &#xa0;A, Sklinda &#xa0;K, Durlik &#xa0;M, Wierzba &#xa0;W, Cossarizza &#xa0;A, Piwocka &#xa0;K. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol &#xa0;2022;13:886431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin &#xa0;K, Peluso &#xa0;MJ, Thomas &#xa0;R, Shin &#xa0;M-G, Neidleman &#xa0;J, Luo &#xa0;X, Hoh &#xa0;R, Anglin &#xa0;K, Huang &#xa0;B, Argueta &#xa0;U, Lopez &#xa0;M, Valdivieso &#xa0;D, Asare &#xa0;K, Ibrahim &#xa0;R, St&#xe4;ndker &#xa0;L, Lu &#xa0;S, Goldberg &#xa0;SA, Lee &#xa0;SA, Lynch &#xa0;KL, Kelly &#xa0;JD, Martin &#xa0;JN, M&#xfc;nch &#xa0;J, Deeks &#xa0;SG, Henrich &#xa0;TJ, Roan &#xa0;NR. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol &#xa0;2024;25:218&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy &#xa0;L, Hanson &#xa0;BA, Orban &#xa0;ZS, Lim &#xa0;PH, Palacio &#xa0;NM, Jimenez &#xa0;M, Clark &#xa0;JR, Graham &#xa0;EL, Liotta &#xa0;EM, Tachas &#xa0;G, Penaloza-MacMaster &#xa0;P, Koralnik &#xa0;IJ. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID. bioRxiv 21261763. 10.1101/2021.08.08.21261763, 21 October 2022, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha &#xa0;M-S, Jeong &#xa0;HW, Ko &#xa0;J-H, Choi &#xa0;SJ, Seo &#xa0;I-H, Lee &#xa0;JS, Sa &#xa0;M, Kim &#xa0;AR, Joo &#xa0;E-J, Ahn &#xa0;JY, Kim &#xa0;JH, Song &#xa0;K-H, Kim &#xa0;ES, Oh &#xa0;DH, Ahn &#xa0;MY, Choi &#xa0;HK, Jeon &#xa0;JH, Choi &#xa0;J-P, Kim &#xa0;HB, Kim &#xa0;YK, Park &#xa0;S-H, Choi &#xa0;WS, Choi &#xa0;JY, Peck &#xa0;KR, Shin &#xa0;E-C. PD-1-expressing SARS-CoV-2-specific CD8+ T cells are not exhausted, but functional in patients with COVID-19. Immunity &#xa0;2021;54:44&#x2013;52.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi &#xa0;M, Erdem &#xa0;SS, Weissleder &#xa0;R, Lichtman &#xa0;AH, McCarthy &#xa0;JR, Libby &#xa0;P. Imaging granzyme B activity assesses immune-mediated myocarditis. Circ Res &#xa0;2015;117:502&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4553143</ArticleId><ArticleId IdType="pubmed">26199323</ArticleId></ArticleIdList></Reference><Reference><Citation>Makunts &#xa0;T, Saunders &#xa0;IM, Cohen &#xa0;IV, Li &#xa0;M, Moumedjian &#xa0;T, Issa &#xa0;MA, Burkhart &#xa0;K, Lee &#xa0;P, Patel &#xa0;SP, Abagyan &#xa0;R. Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data. Sci Rep &#xa0;2021;11:17324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8405813</ArticleId><ArticleId IdType="pubmed">34462476</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura &#xa0;H, Okazaki &#xa0;T, Tanaka &#xa0;Y, Nakatani &#xa0;K, Hara &#xa0;M, Matsumori &#xa0;A, Sasayama &#xa0;S, Mizoguchi &#xa0;A, Hiai &#xa0;H, Minato &#xa0;N, Honjo &#xa0;T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science &#xa0;2001;291:319&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">11209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Love &#xa0;VA, Grabie &#xa0;N, Duramad &#xa0;P, Stavrakis &#xa0;G, Sharpe &#xa0;A, Lichtman &#xa0;A. CTLA-4 Ablation and interleukin-12&#x2013;driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circ Res &#xa0;2007;101:248&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">17569889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekkens &#xa0;MJ, Shedlock &#xa0;DJ, Jung &#xa0;E, Troy &#xa0;A, Pearce &#xa0;EL, Shen &#xa0;H, Pearce &#xa0;EJ. Th1 and Th2 cells help CD8 T-cell responses. Infect Immun &#xa0;2007;75:2291&#x2013;2296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865742</ArticleId><ArticleId IdType="pubmed">17325050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye &#xa0;L-L, Wei &#xa0;X-S, Zhang &#xa0;M, Niu &#xa0;Y-R, Zhou &#xa0;Q. The significance of tumor necrosis factor receptor type II in CD8+ regulatory T cells and CD8+ effector T cells. Front Immunol &#xa0;2018;9:583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5874323</ArticleId><ArticleId IdType="pubmed">29623079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant &#xa0;D, Becker &#xa0;L, Richardson &#xa0;J, Shelton &#xa0;J, Franc &#xa0;F, Peshock &#xa0;R, Thompson &#xa0;M, Giroir &#xa0;B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-&#x3b1;. Circulation &#xa0;1998;97:1375&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">9577949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrigley &#xa0;BJ, Lip &#xa0;GYH, Shantsila &#xa0;E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Hear Fail &#xa0;2011;13:1161&#x2013;1171.</Citation><ArticleIdList><ArticleId IdType="pubmed">21952932</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Garcia &#xa0;J, Jaladanki &#xa0;S, Rivas-Lasarte &#xa0;M, Cagliostro &#xa0;M, Gupta &#xa0;A, Joshi &#xa0;A, Ting &#xa0;P, Mitter &#xa0;SS, Bagiella &#xa0;E, Mancini &#xa0;D, Lala &#xa0;A. New heart failure diagnoses among patients hospitalized for COVID-19. J Am Coll Cardiol &#xa0;2021;77:2260&#x2013;2262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074874</ArticleId><ArticleId IdType="pubmed">33926664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>